Skip to main content



Local Cdiff information for Virginia

Virginia

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Virginia.



Local Cdiff information for Virginia

Virginia

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Virginia.

Providers

Dr. C. Taylor Richardson, MD

Richmond Gastroenterology Associates
5875 Bremo Road, Suite 601
Richmond, 23226
804-673-2806
FMT Provider: Yes
VISIT WEBSITE >

Dr. Amira Ibrahim

Advanced Gastroenterology Specialists
7611 Forest Ave. Suite 330
Richmond, 23229
(804) 219-4800
FMT Provider: Yes
VISIT WEBSITE >

Dr. Brian W. Behm, MD

Associate Professor of Medicine, University of Virginia Health System, Charlottesville, VA
Digestive Health Center
Main Floor
1215 Lee Street
Charlottesville, 22903
434-243-3090
FMT Provider: No
VISIT WEBSITE >

Dr. Suchitra Hourigan, MD

Pediatric Specialists of Virginia
3023 Hamaker Ct 600
Fairfax, 22031
703-876-2788
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 1548
Hospital Onset: 1548
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.62
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Andrea Alvarez, MPH
Healthcare-Associated Infections Epidemiologist
Virginia Department of Health
Division of Surveillance and Investigation
109 Governor St, 5th Floor
Richmond, 23219
804.864.8097
804.864-8139
EMAIL ANDREA ALVAREZ, MPH >

CLINICAL TRIALS

ACT

Official Title: Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection: A Randomized, Double-blind, Placebo-controlled Trial
Trial No. NCT04305769
Type: Interventional
Recruitment: Recruiting
Sponsor: University of Virginia
Contact: Cirle Warren, M.D.
434-270-1082
EMAIL
Gender: All
Age: 18 Years to 105 Years

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

PRISM

Official Title: A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above
Trial No. NCT07285213
Type: Interventional
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: See trial website for site-specific contacts
Gender: All
Age: 18 Years and older

BEETHOVEN

Official Title: A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER
Trial No. NCT07282665
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: See trial website for site-specific contacts
Gender: All
Age: 65 Years and older